Skip to content

A clinical trial to test the safety of a herbal drug.

A phase 1 clinical trial for assessment of safety of a multi component botanical therapeutic SKBOM.

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/11/010352
Enrollment
100
Registered
2017-11-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: SKBOM: Keep 100-200 mgs of SKBOM on tongue and allow to dissolve slowly in oral cavity. Repeat this 4-5 times per day continuously for 15 days. Control Intervention1: No comparator agen

Sponsors

SK Biolabs
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult healthy human volunteers.

Exclusion criteria

Exclusion criteria: Patients suffering from any disease.

Design outcomes

Primary

MeasureTime frame
Any toxic side effects by keeping SKBOM on tongue such as nausea, vomiting, fever, trouble swallowing, weakness, palpitations, stomach upset, stomach gas, heartburn, skin rashes, dizziness, fainting, depression, anxiety, constipation, diarrhea, dark stool, urinary problems, pain, cramps etc.Timepoint: 1 hour

Secondary

MeasureTime frame
Any toxic side effects by keeping SKBOM on tongue such as nausea, vomiting, fever, trouble swallowing, weakness, palpitations, stomach upset, stomach gas, heartburn, skin rashes, dizziness, fainting, depression, anxiety, constipation, diarrhea, dark stool, urinary problems, pain, cramps etc.Timepoint: 15 days

Countries

India

Contacts

Public ContactDr Ashok Kumar

SK Biotherapeutics Pvt. Ltd. (Previously SK Biolabs)

ashok846@gmail.com8126688922

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026